取引所：IOB セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
IOB (25)
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
バイオテクノロジー (25)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novo Nordisk A/S 0QIU.IL | $435.25 63.82 USD |
-0.85
|
$1.83T 267.97B USD | $2.55M 373.62K USD | $424.3 62.21 USD | $439 64.37 USD | $1.83T 267.97B USD | 29.29 | $14.86 2.18 USD | |
| UCB SA 0NZT.IL | $154.03 168.37 USD |
0
|
$31.34B 34.26B USD | $24.02K 26.25K USD | $151.25 165.34 USD | $154.5 168.89 USD | $31.34B 34.26B USD | 90.60 | $1.7 1.86 USD | |
| argenx SE 0QW0.IL | $479.25 523.89 USD |
-0.16
|
$28.19B 30.82B USD | $18.76K 20.51K USD | $477.4 521.86 USD | $487.1 532.47 USD | $28.19B 30.82B USD | 0 | -$6.55 -7.1 USD | |
| Genmab A/S 0MGB.IL | $1,297 190.17 USD |
-0.56
|
$103.86B 15.23B USD | $11.12K 1.63K USD | $1,278 187.38 USD | $1,303.25 191.08 USD | $103.86B 15.23B USD | 18.32 | $70.77 10.38 USD | |
| Moderna, Inc. 0A45.IL | $23.53 — |
-3.78
|
$11.44B — | $45.28K — | $23.17 — | $24.3 — | $11.44B — | 8.77 | $2.68 — | |
| Galapagos NV 0JXZ.IL | $23.71 25.92 USD |
-0.84
|
$1.56B 1.71B USD | $13.13K 14.35K USD | $23.38 25.56 USD | $23.92 26.15 USD | $1.56B 1.71B USD | 0 | -$2.44 -2.6 USD | |
| CureVac N.V. 0A9E.IL | $3.39 — |
-1.17
|
$845.54M — | $77 — | $3.35 — | $3.42 — | $845.54M — | 0 | -$1.5 — | |
| Pharming Group N.V. 0QCO.IL | $0.8199 0.9 USD |
-1.41
|
$645.89M 706.05M USD | $59.46K 65K USD | $0.8199 0.9 USD | $0.8399 0.92 USD | $645.89M 706.05M USD | 0 | -$0.02 -0.02 USD | |
| Idorsia Ltd 0RQE.IL | $1.3 1.48 USD |
-1.67
|
$329.37M 374.75M USD | $216 245.76 USD | $1.3 1.48 USD | $1.31 1.49 USD | $329.37M 374.75M USD | 0 | -$4.57 -5.1 USD | |
| DBV Technologies S.A. 0QAJ.IL | $2 2.18 USD |
-11.46
|
$226.46M 247.55M USD | $18.28K 19.98K USD | $1.96 2.14 USD | $2.2 2.4 USD | $226.46M 247.55M USD | 0 | -$0.93 -1.01 USD | |
| Poxel S.A. 0RA2.IL | $0.4 0.44 USD |
-1.04
|
$14.22M 15.55M USD | $20.19K 22.07K USD | $0.4 0.44 USD | $0.4099 0.44 USD | $14.22M 15.55M USD | 0 | -$1.09 -1.1 USD | |
| BioNTech SE 0A3M.IL | $92.75 — |
-0.54
|
$25.51B — | $2.16K — | $90 — | $93.59 — | $25.51B — | 5.15 | $18 — | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $41.91K 6.15K USD | $162.8 23.87 USD | $168.2 24.66 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Zealand Pharma A/S 0NZU.IL | $402.85 59.07 USD |
-1.2
|
$24.02B 3.52B USD | $45.61K 6.69K USD | $399.5 58.58 USD | $408.75 59.93 USD | $24.02B 3.52B USD | 0 | -$15.13 -2.2 USD | |
| MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
| Bavarian Nordic A/S 0DPB.IL | $163.43 23.96 USD |
+1.24
|
$15.34B 2.25B USD | $6.45K 945.12 USD | $162.55 23.83 USD | $166.3 24.38 USD | $15.34B 2.25B USD | 11.59 | $14.09 2.07 USD | |
| BioArctic AB (publ) 0RV2.IL | $175.35 17.12 USD |
-0.17
|
$17.54B 1.71B USD | $16.51K 1.61K USD | $171.1 16.7 USD | $175.7 17.15 USD | $17.54B 1.71B USD | 57.11 | $3.07 0.3 USD | |
| Pharma Mar, S.A. 0RC6.IL | $76.4 83.52 USD |
+2
|
$1.38B 1.51B USD | $381 416.48 USD | $73.15 79.96 USD | $77.85 85.1 USD | $1.38B 1.51B USD | 68.82 | $1.11 1.21 USD | |
| Genfit S.A. 0QT6.IL | $3.65 3.99 USD |
-4.35
|
$194.72M 212.85M USD | $21 22.96 USD | $3.65 3.99 USD | $3.77 4.12 USD | $194.72M 212.85M USD | 0 | -$0.67 -0.7 USD | |
| BioInvent International AB (publ) 0H22.IL | $30.15 2.94 USD |
+8.75
|
$2.12B 207.07M USD | $1.24K 121.23 USD | $33.35 3.26 USD | $33.35 3.26 USD | $2.12B 207.07M USD | 0 | -$5.01 -0.4 USD | |
| Innate Pharma S.A. 0EVI.IL | $1.92 2.1 USD |
-2.04
|
$154.96M 169.4M USD | $5.41K 5.91K USD | $1.92 2.1 USD | $1.96 2.14 USD | $154.96M 169.4M USD | 0 | -$0.78 -0.8 USD | |
| Hansa Biopharma AB (publ) 0RC7.IL | $24.92 2.43 USD |
+0.61
|
$1.64B 160.04M USD | $100 9.76 USD | $24.8 2.42 USD | $24.8 2.42 USD | $1.64B 160.04M USD | 0 | -$16.03 -1.5 USD | |
| Cellectis S.A. 0WA2.IL | $1.36 1.49 USD |
+4.29
|
$98.34M 107.5M USD | $0 0 USD | $1.36 1.49 USD | $1.36 1.49 USD | $98.34M 107.5M USD | 0 | -$1.42 -1.5 USD | |
| Thor Medical ASA 0R6Y.IL | $2.48 0.24 USD |
+0.41
|
$710.25M 68.13M USD | $1.7K 162.69 USD | $2.44 0.23 USD | $2.44 0.23 USD | $710.25M 68.13M USD | 0 | -$1.17 -0.1 USD | |
| Oncopeptides AB (publ) 0RN4.IL | $1.94 0.19 USD |
-2.64
|
$198.81M 19.41M USD | $333.55K 32.56K USD | $1.95 0.19 USD | $1.95 0.19 USD | $198.81M 19.41M USD | 0 | -$3.39 -0.3 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||
- {{ link.label }} {{link}}